Tobie D. Lee

机构：Baylor College of Medicine, Quantitative BioSciences, Breast Center · ORCID：0000-0001-5331-2997

发表论文 61 篇 · 总被引 1871 次 · h-index 17

代表论文

• Pan-cancer proteogenomics expands the landscape of therapeutic targets (2024 · Cell · 被引 115)
• Conditional lethality profiling reveals anticancer mechanisms of action and drug-nutrient interactions (2024 · Science Advances · 被引 18)
• High-throughput screening identifies Aurora kinase B as a critical therapeutic target for Merkel cell carcinoma (2025 · Nature Communications · 被引 5)
• Conditional lethality profiling reveals anticancer mechanisms of action and drug-nutrient interactions (2023 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 5)
• Inflammation- and resolution-programmed myeloid circuits govern therapeutic resistance in epithelial and mesenchymal triple-negative breast cancer (2026 · Journal of Clinical Investigation · 被引 1)
• Table S1 from ICAM1<sup>high</sup> Neutrophils Sculpt Tumor Evolution and Metastasis Through Symbiotic Adhesion and Reverse Migration (2026)